基于视觉刺激的图片疗法对脑卒中后 抑郁的疗效分析

目的 探究基于视觉刺激的图片疗法对脑卒中后抑郁（PSD）症状及神经功能恢复的疗效。 方法 选取2018 年3 月—2018 年11 月哈尔滨医科大学附属第四医院收治的60 例PSD 患者，随机分为对照 组20 例和研究组40 例。对照组采用早期康复和脑卒中常规抗抑郁药物治疗。研究组在对照组基础上采用基 于视觉刺激的图片疗法治疗1 个月。其中，将研究组再次随机分为图片疗法15 min 组和30 min 组，每组20 例。 结果 3 组患者治疗前HAMD、mRS 评分比较，差异无统计学意义（P >0.05）。3 组患者治疗前后HAMD、 mRS 评分差值比较，差异有统计学意义（P <0.05）。图片疗法15 min 组和30 min 组治疗前后HAMD、mRS 评分差值与对照组比较，差异有统计学意义（P <0.05）；图片疗法30 min 组与图片疗法15 min 组治疗前后 HAMD、mRS 评分差值比较，差异有统计学意义（P <0.05）。结论 在PSD 患者早期康复和常规药物治疗的 同时应用基于视觉刺激的图片疗法，有助于改善PSD 症状及促进神经功能恢复，值得临床进一步推广。

Therapeutic effect of picture therapy based on visual stimulation on post-stroke depression

Objective To explore the efficacy of visual stimuli-based phototherapy for post-stroke depression (PSD) and neurological recovery. Methods From March 2018 to November 2018, 60 patients with post-stroke depression in our hospital were selected. They were divided into 2 groups: 20 patients in the control group, with early rehabilitation and conventional antidepressant medication for post-stroke depression, and 40 patients in the study group treated with visual stimulation-based phototherapy for 1 month on the basis of the control group. The study group was again randomly divided into a 15-minute group and 30-minute group for phototherapy, 20 patients in each group. Results There were no significant differences in the Hamilton Depression Scale (Hamilton, HAMD) and Modified Rankin Scale (mRS) scores among the three groups before treatment (P > 0.05). After 1 month of treatment, the HAMD and mRS scores of the three groups were lower than those before treatment, and the difference was statistically significant (P < 0.05); the differences of HAMD and mRS scores before and after the treatment between the 15-minute group and the 30-minute group for phototherapy were statistically significant (P < 0.05); the differences of HAMD and mRS scores before and after the treatment between the 15-minute group and the 30-minute group for phototherapy were not statistically significant (P < 0.05). Conclusion For patients with post-stroke depression, the use of visual stimulation-based phototherapy therapy in early rehabilitation and conventional drug therapy improve the symptoms of post-stroke depression and promote the recovery of neurological function, which is worthy of further clinical promotion.